PEDIATRICS Vol. 101 No. 2 February 1998, pp. 185-193
Effect of Allopurinol on Postasphyxial Free Radical Formation, Cerebral Hemodynamics, and Electrical Brain Activity
Received Feb 2, 1997; accepted Oct 10, 1997.
,
From the * Department of Pediatrics, Leiden University Hospital,
Leiden, The Netherlands, and the Department of Neonatology,
Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Objective. Free radical-induced postasphyxial reperfusion injury has been recognized as an important cause of brain tissue damage. We investigated the effect of high-dose allopurinol (ALLO; 40 mg/kg), a xanthine-oxidase inhibitor and free radical scavenger, on free radical status in severely asphyxiated newborns and on postasphyxial cerebral perfusion and electrical brain activity.
Methods. Free radical status was assessed by serial plasma
determination of nonprotein-bound iron (µM),
antioxidative capacity, and malondialdehyde (MDA; µM).
Cerebral perfusion was investigated by monitoring changes in cerebral
blood volume (
CBV; mL/100 g brain tissue) with near infrared
spectroscopy; electrocortical brain activity (ECBA) was assessed in
microvolts by cerebral function monitor. Eleven infants received 40 mg/kg ALLO intravenously, and 11 infants served as controls (CONT).
Plasma nonprotein-bound iron, antioxidative capacity, and MDA were
measured before 4 hours, between 16 and 20 hours, and at the second and
third days of age. Changes in CBV and ECBA were monitored between 4 and
8, 16 and 20, 58 and 62, and 104 and 110 hours of age.
Results. Six CONT and two ALLO infants died after
neurologic deterioration. No toxic side effects of ALLO were detected.
Nonprotein-bound iron (mean ± SEM) in the CONT group showed an
initial rise (18.7 ± 4.6 µM to 21.3 ± 3.4 µM) but dropped to 7.4 ± 3.5 µM at
day 3; in the ALLO group it dropped from 15.5 ± 4.6 µM to 0 µM at day 3. Uric acid was
significantly lower in ALLO-treated infants from 16 hours of life on.
MDA remained stable in the ALLO group, but increased in the CONT group
at 8 to 16 hours versus <4 hours (mean ± SEM; 0.83 ± 0.31 µM vs 0.50 ± 0.14 µM). During 4 to 8 hours, CBV-CONT showed a larger drop than CBV-ALLO from
baseline. During the subsequent registrations CBV remained stable in
both groups. ECBA-CONT decreased, but ECBA-ALLO remained stable
during 4 to 8 hours of age. Neonates who died had the largest drops in CBV and ECBA.
Conclusion. This study suggests a beneficial effect of ALLO treatment on free radical formation, CBV, and electrical brain activity, without toxic side effects.
Key words: birth asphyxia, allopurinol, side effects, free radicals, brain perfusion, electrical brain activity.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  H. L. Torrance, M. J. Benders, J. B. Derks, C. M. A. Rademaker, A. F. Bos, P. Van Den Berg, M. Longini, G. Buonocore, M. Venegas, H. Baquero, et al. Maternal Allopurinol During Fetal Hypoxia Lowers Cord Blood Levels of the Brain Injury Marker S-100B Pediatrics, July 1, 2009; 124(1): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J N L Benders, A F Bos, C M A Rademaker, M Rijken, H L Torrance, F Groenendaal, and F van Bel Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F163 - F165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, A. Nivorozhkin, and C. Szabo Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Perlman Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics, March 1, 2006; 117(3 Pt 2): S28 - S33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Toet, P. M.A. Lemmers, L. J. van Schelven, and F. van Bel Cerebral Oxygenation and Electrical Activity After Birth Asphyxia: Their Relation to Outcome Pediatrics, February 1, 2006; 117(2): 333 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Warner, H. Sheng, and I. Batinic-Haberle Oxidants, antioxidants and the ischemic brain J. Exp. Biol., August 15, 2004; 207(18): 3221 - 3231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Clancy, S. A. McGaurn, J. E. Goin, D. G. Hirtz, W. I. Norwood, J. W. Gaynor, M. L. Jacobs, G. Wernovsky, W. T. Mahle, J. D. Murphy, et al. Allopurinol Neurocardiac Protection Trial in Infants Undergoing Heart Surgery Using Deep Hypothermic Circulatory Arrest Pediatrics, July 1, 2001; 108(1): 61 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Hirano, T Morinobu, H Kim, M Hiroi, R Ban, S Ogawa, H Ogihara, H Tamai, and T Ogihara Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2001; 84(3): 188F - 193. [Abstract] [Full Text]
|
|
|
|
|
|
V. Fellman and L. von Bonsdorff Exogenous Apotransferrin and Exchange Transfusions in Hereditary Iron Overload Disease Pediatrics, February 1, 2000; 105(2): 398 - 401. [Abstract] [Full Text]
|
|
|
|
|
|
M C Toet, L Hellström-Westas, F Groenendaal, P Eken, and L S de Vries Amplitude integrated EEG 3 and 6 hours after birth in full term neonates with hypoxic-ischaemic encephalopathy Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1999; 81(1): 19F - 23. [Abstract] [Full Text]
|
|
